Drugs -- TestingHere are entered works on testing the effectiveness or safety of drugs. Works on testing to identify the personal use or misuse of drugs are entered under Drug testing. Technical works on chemical analysis to determine the composition or presence of drugs are entered under Drugs -- Analysis. See also what's at your library, or elsewhere.
Broader terms:Narrower terms:Used for:- Clinical drug trials
- Clinical trials of drugs
- Drug bioscreening
- Drugs -- Clinical trials
- Drugs -- Effectiveness -- Testing
- Drugs -- Evaluation
- Drug trials
|
Filed under: Drugs -- Testing- Postmarketing Surveillance of Prescription Drugs (1982), by United States Congress Office of Technology Assessment
- Drug Bioequivalence (1974), by United States Congress Office of Technology Assessment (PDF files at Princeton)
- Testing Drugs for Physical Dependence Potential and Abuse Liability, ed. by Joseph V. Brady and Scott E. Lukas (PDF at NIH)
- Drug bioequivalence : a report of the Office of Technology Assessment, Drug Bioequivalence Study Panel (The Office :, 1974), by United States. Drug Bioequivalence Study Panel (page images at HathiTrust)
- Guidelines for the clinical evaluation of hypnotic drugs. (Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration ;, 1977), by United States Food and Drug Administration (page images at HathiTrust)
- Guidelines for the clinical evaluation of antidiarrheal drugs. (Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration ;, 1977), by United States Food and Drug Administration (page images at HathiTrust)
- Guidelines for the clinical evaluation of anti-arrhythmic drugs. (Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration ;, 1977), by United States Food and Drug Administration (page images at HathiTrust)
- Guidelines for the clinical evaluation of gastric secretory depressant (GSD) drugs. (Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration, 1977), by United States Food and Drug Administration (page images at HathiTrust)
- General considerations for the clinical evaluation of drugs in infants and children. (Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration ;, 1977), by United States. Food and Drug Administration. Bureau of Drugs (page images at HathiTrust)
- Guidelines for the clinical evaluation of antidepressant drugs. (U.S. Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration ;, 1977), by United States. Food and Drug Administration. Bureau of Drugs (page images at HathiTrust)
- Guidelines for the clinical evaluation of anticonvulsant drugs (adults and children). (U.S. Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration ;, 1977), by United States. Food and Drug Administration. Bureau of Drugs (page images at HathiTrust)
- Guidelines for the clinical evaluation of general anesthetics. (U.S. Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration, 1977), by United States. Food and Drug Administration. Bureau of Drugs (page images at HathiTrust)
- Guidelines for the clinical evaluation of anti-anginal drugs. (U.S. Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration ;, 1977), by United States. Food and Drug Aministration. Bureau of Drugs (page images at HathiTrust)
- Guidelines for the clinical evaluation of anti-inflammatory drugs (adults and children). (U.S. Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration, 1978), by United States. Food and Drug Administration. Bureau of Drugs (page images at HathiTrust)
- Guidelines for the clinical evaluation of antianxiety drugs. (U.S. Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration ;, 1977), by United States. Food and Drug Administration. Bureau of Drugs (page images at HathiTrust)
- Guidelines for the clinical evaluation of anti-infective drugs (systemic) (adults and children). (U.S. Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration ;, 1977), by United States. Food and Drug Administration. Bureau of Drugs (page images at HathiTrust)
- Guidelines for the clinical evaluation of local anesthetics. (U.S. Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration ;, 1977), by United States. Food and Drug Administration. Bureau of Drugs (page images at HathiTrust)
- General considerations for the clinical evaluation of drugs. (U.S. Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration ;, 1977), by United States. Food and Drug Administration. Bureau of Drugs (page images at HathiTrust)
- Tests and standards for new and nonofficial remedies; containing tests and standards for nonofficial drugs and dosage forms which stand accepted by the Council on Pharmacy and Chemistry of the American Medical Association on January 1, 1953. (Lippincott, 1953), by Chemical Laboratory (American Medical Association) (page images at HathiTrust)
- Tests and standards for new and nonofficial remedies. [Supplement] (American Medical Association, 1955), by Chemical Laboratory (American Medical Association) (page images at HathiTrust)
- Report of Joint Commission on Prescription Drug Use. Final report, January 23, 1980. (Joint Commission on Prescription Drug Use, 1980), by Joint Commission on Prescription Drug Use (page images at HathiTrust; US access only)
- NCI investigational drugs : pharmaceutical data, 1990. (U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, 1990), by National Cancer Institute (U.S.). Pharmaceutical Resources Branch and National Cancer Institute (U.S.) (page images at HathiTrust)
- The request of the National Institutes of Health for a limited exemption from the Freedom of Information Act (U.S. Dept. of Health and Human Services, 1980), by United States. Department of Health and Human Services. Ethics Advisory Board (page images at HathiTrust)
- Competitive problems in the drug industry : drug testing : summary and analysis (U.S. Govt. Print. Off., 1979), by Library of Congress. Congressional Research Service, Janet E. Lemke, and United States. Congress. Senate. Select Committee on Small Business (page images at HathiTrust)
- Preclinical and clinical testing by the pharmaceutical industry, 1979 hearing before the Subcommittee on Health and Scientific Research of the Committee on Labor and Human Resources, United States Senate, Ninety-sixth Congress, first session ... October 11, 1979. (U.S. Govt. Print. Off., 1979), by United States. Congress. Senate. Committee on Labor and Human Resources. Subcommittee on Health and Scientific Research (page images at HathiTrust)
- Review time has decreased in recent years (The Office ;, 1995), by United States General Accounting Office (page images at HathiTrust)
- Guidelines for the clinical evaluation of laxative drugs. (Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration ;, 1978), by United States Food and Drug Administration (page images at HathiTrust)
- Guidelines for the clinical evaluation of drugs to prevent, control and/or treat periodontal disease. (Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration;, 1978), by United States Food and Drug Administration (page images at HathiTrust)
- Lipid-altering agents in adults and children (United States Government Printing Office, 1980), by United States. Food and Drug Administration. Division of Metabolism and Endocrine Drug Products, United States Department of Health and Human Services, and United States. Food and Drug Administration. Bureau of Drugs (page images at HathiTrust)
- Guidelines for the clinical evaluation of antacid drugs. (Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration, Division of Cardio-Renal Drug Products, Bureau of Drugs ;, 1978), by United States. Food and Drug Administration. Bureau of Drugs (page images at HathiTrust)
- Guidelines for the clinical evaluation of bronchodilator drugs. (Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration ;, 1978), by United States Food and Drug Administration (page images at HathiTrust)
- Guidelines for the clinical evaluation of antiepileptic drugs (adults and children) (U.S. Dept. of Health and Human Services, Public Health Service, Food and Drug Administration ;, 1981), by United States Food and Drug Administration (page images at HathiTrust)
- Guidelines for the clinical evaluation of G.I. motility-modifying drugs. (Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration ;, 1978), by United States Food and Drug Administration (page images at HathiTrust)
- Guidelines for the clinical evaluation of drugs used in the treatment of osteoporosis. (Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration;, 1979), by United States. Food and Drug Administration. Division of Metabolism and Endocrine Drug Products and United States Food and Drug Administration (page images at HathiTrust)
- The FDA Commission : the delegation of authority to state and local authorities. (U.S. Dept. of Human Services, Public Health Service, Food and Drug Administration, 1989), by United States Food and Drug Administration and United States Department of Health and Human Services (page images at HathiTrust)
- Guidelines for the clinical evaluation of drugs to prevent dental caries. (Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration ;, 1978), by United States Food and Drug Administration (page images at HathiTrust)
- Guidelines for the clinical evaluation of antineoplastic drugs. (U.S. Dept. of Health and Human Services, Public Health Service, Food and Drug Administration ;, 1981), by United States Food and Drug Administration (page images at HathiTrust)
- Clinical trials of medical treatments (Dept. of Health and Human Services, Food and Drug Administration, 2001), by United States Food and Drug Administration (page images at HathiTrust)
- Taschenbuch bestbewährter Vorschriften für die gangbarsten Handverkaufs-Artikel der Apotheken und Drogenhandlungen (A. Hartleben, 1904), by Adolf Vomáčka (page images at HathiTrust; US access only)
- Adequacy of access to investigative drugs for seriously ill patients : hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fifth Congress, first session, September 23, 1997. (U.S. G.P.O. :, 1997), by United States House Committee on Commerce, Subcommittee on Oversight and Investigations (page images at HathiTrust)
- New drug evaluation : statistical report ([Rockville, Md.] : U.S. Dept. of Health and Human Services, Public Health Service, Food and Drug Administration, Center for Drugs and Biologics, Office of Management ;, 1987), by United States. National Technical Information Service (page images at HathiTrust)
- The Final report (The Commission, 1980), by Joint Commission on Prescription Drug Use (page images at HathiTrust)
- The documentation of clinical psychotropic drug trails (National Institute of Mental Health, 1973), by Thomas H. McGlashan and National Institute of Mental Health (U.S.) (page images at HathiTrust)
- Investigator's handbook : a manual for participants in clinical trials of investigational agents sponsored by the Division of Cancer Treatment, National Cancer Institute. (Cancer Therapy Evaluation Program, Division of Cancer Treatment, National Cancer Institute, 1987), by National Cancer Institute (U.S.). Cancer Therapy Evaluation Program (page images at HathiTrust)
- Chemical spot test kits for preliminary identification of drugs of abuse (U.S. Dept. of Justice, Law Enforcement Assistance Administration, National Institute of Law Enforcement and Criminal Justice :, 1978), by National Institute of Law Enforcement and Criminal Justice and Law Enforcement Standards Program (U.S.) (page images at HathiTrust)
- Preclinical and clinical testing by the pharmaceutical industry, 1975[-1976] : joint hearings before the Subcommittee on Health of the Committee on Labor and Public Welfare and the Subcommittee on Administrative Practice and Procedure of the Committee on the Judiciary, United States Senate, Ninety-fourth Congress, second session, on examination of the process of drug testing and FDA's role in the regulation and conditions under which such testing is carried out. (U.S. Govt. Print. Off, 1975), by United States. Congress. Senate. Committee on Labor and Public Welfare. Subcommittee on Health and United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Administrative Practice and Procedure (page images at HathiTrust)
- Preclinical and clinical testing by the pharmaceutical industry, 1979 : hearing before the Subcommittee on Health and Scientific Research of the Committee on Labor and Human Resources, United States Senate, Ninety-sixth Congress, first session, on examination of the process of drug testing and FDA's role in the process, October 11, 1979. (U.S. Govt. Print. Off. :, 1979), by United States. Congress. Senate. Committee on Labor and Human Resources. Subcommittee on Health and Scientific Research and United States Food and Drug Administration (page images at HathiTrust)
- Preclinical and clinical testing by the pharmaceutical industry, 1976 : joint hearings before the Subcommittee on Health of the Committee on Labor and Public Welfare and the Subcommittee on Administrative Practice and Procedure of the Committee on the Judiciary, United States Senate, Ninety-fourth Congress, second session, on examination of the process of drug testing and FDA's role in the regulation and conditions under which such testing is carried out. (U.S. Govt. Print. Off, 1975), by United States. Congress. Senate. Committee on Labor and Public Welfare. Subcommittee on Health and United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Administrative Practice and Procedure (page images at HathiTrust)
- FDA introduction to total drug quality. ([Rockville, Md.] : [U.S. Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration]] ; [[Washington] : [For sale by the Supt. of Docs., U.S. Govt. Print.], [1973], 1973), by United States Food and Drug Administration (page images at HathiTrust)
- Budget amendment for program of monitoring the testing of drugs and food additives : communication from the President of the United States ... April 26, 1976. (U.S. Govt. Print. Off., 1976), by United States. President (1974-1977 : Ford) (page images at HathiTrust)
- Guidelines for the clinical evaluation of anti-inflammatory and antirheumatic drugs (adults and children) (U.S. Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration, 1988), by United States. Food and Drug Administration. Bureau of Drugs (page images at HathiTrust)
- Summary of the report of the Advisory Review Panel (Dept. of Health, Education, and Welfare, Public Health Service, Food and Drug Administration, Office of Public Affairs, 1977), by Antipyretic United States. Food and Drug Administration. Advisory Review Panel on OTC Internal Analgesic and United States Food and Drug Administration (page images at HathiTrust)
More items available under narrower terms. |